�鶹ԭ��

Year-to-date change (as of Oct. 1, 2018 close): 171.48%

Last price: $7.33

Year-to-date price gain: $4.63

Year-to-date high: $12.75

Year-to-date low: $2.45

Though might not be a household name yet, this company that manufactures products like coaxial cables and data center equipment has certainly made a name for itself in the industry. In the second quarter of the 2018 fiscal year, the company .

Year-to-date change (as of Oct. 1, 2018 close): 174.39%

Last price: $21.32

Year-to-date price gain: $13.55

Year-to-date high: $32.17

Year-to-date low: $7.16

This fashion company carries a , such as Fossil, Skagen, and Relic, and makes watches and accessories that are licensed under big names like Kate Spade, Armani, and Tory Burch. A indicates that Fossil Group is investing in innovative technologies like smartwatch capabilities.

Year-to-date change (as of Oct. 1, 2018 close): 178.28%

Last price: $6.15

Year-to-date price gain: $3.94

Year-to-date high: $6.39

Year-to-date low: $1.73

An independent oil and natural gas company operating in the Gulf Coast and Rocky Mountain regions, increased its adjusted cash flow from operations in 2018. in the second quarter, as well.

Year-to-date change (as of Oct. 1, 2018 close): 178.57%

Last price: $78.14

Year-to-date price gain: $50.09

Year-to-date high: $91.16

Year-to-date low: $28.10

This health care company specializes in , creating technologies that allow prescribers, pharmacists, and health care organizations to mitigate the risk of various medications. Tabula Rasa recently acquired Mediture and eClusive, an electronic health record company and provider of third-party administrator services, respectively.  

Year-to-date change (as of Oct. 1, 2018 close): 178.84%

Last price: $46.51

Year-to-date price gain: $29.83

Year-to-date high: $52.95

Year-to-date low: $16.38

Ptc Therapeutics is a global pharmaceutical company that focuses on . Ptc scientists primarily work on .

Year-to-date change (as of Oct. 1, 2018 close): 180.44%

Last price: $71.82

Year-to-date price gain: $46.21

Year-to-date high: $75.49

Year-to-date low: $25.13

Many businesses use to confirm the identities of their workers and allow secure sign-ons to their networks out of the office—a valuable commodity in the increasingly mobile workforce. Experts note that of identity security companies like Okta.  

Year-to-date change (as of Oct. 1, 2018 close): 180.59%

Last price: $97.28

Year-to-date price gain: $62.61

Year-to-date high: $101.15

Year-to-date low: $34.68

This company’s name pays homage to the signature shape of its : a small white card reader that small-business owners can plug into a smartphone. Square for $365 million and launched a .

Year-to-date change (as of Oct. 1, 2018 close): 183.74%

Last price: $3.49

Year-to-date price gain: $2.26

Year-to-date high: $3.88

Year-to-date low: $1.09

This medical technology company develops products for . The FDA —a tip for a dermatological laser—for use.

Year-to-date change (as of Oct. 1, 2018 close): 186.17%

Last price: $17.17

Year-to-date price gain: $11.17

Year-to-date high: $26.35

Year-to-date low: $4.63

Biolife Solutions such as cryopreservation and hypothermic storage for stem cells, tissues, and organs in hospitals and biobanks. With , this company is certainly doing well financially.

Year-to-date change (as of Oct. 1, 2018 close): 197.28%

Last price: $9.84

Year-to-date price gain: $6.53

Year-to-date high: $9.88

Year-to-date low: $3.35

This independent operating in the Gulf of Mexico holds offshore leases for approximately 750,000 acres. Plus, W&T recently announced a partnership with Baker Hughes to use the latter company's engineering expertise to further develop 14 drilling sites.

Year-to-date change (as of Oct. 1, 2018 close): 200.27%

Last price: $11.26

Year-to-date price gain: $7.51

Year-to-date high: $14.29

Year-to-date low: $3.65

Catasys provides services like to health care companies. The company continues to grow—for instance, it recently expanded its On-Trak technology into Florida and Georgia.

Year-to-date change (as of Oct. 1, 2018 close): 200.58%

Last price: $57.47

Year-to-date price gain: $38.35

Year-to-date high: $72.59

Year-to-date low: $16.02

When you buy a used car from Carvana, you can either have it delivered or . Carvana had a somewhat , but recovered in 2018.

Year-to-date change (as of Oct. 1, 2018 close): 203.42%

Last price: $47.03

Year-to-date price gain: $31.53

Year-to-date high: $54.00

Year-to-date low: $13.60

This surgical company specializes in that treat disorders like farsightedness and astigmatism. The FDA recently approved one of its lenses to correct myopia with astigmatism.

Year-to-date change (as of Oct. 1, 2018 close): 203.9%

Last price: $2.34

Year-to-date price gain: $1.57

Year-to-date high: $2.70

Year-to-date low: $0.73

Cas Medical manufactures for use during surgery or other medical treatments.

Year-to-date change (as of Oct. 1, 2018 close): 205.64%

Last price: $31.42

Year-to-date price gain: $21.14

Year-to-date high: $34.14

Year-to-date low: $9.04

This competitor to Intel produces . Recently, AMD's stock has been the , but analysts say a correction is imminent.

Year-to-date change (as of Oct. 1, 2018 close): 208.11%

Last price: $94.22

Year-to-date price gain: $63.64

Year-to-date high: $97.69

Year-to-date low: $30.61

The continued popularity of WWE fights and make it a safe choice for investors, . Fans love its popular “Monday Night Raw” show and the dramatic feuds between characters.  

Year-to-date change (as of Oct. 1, 2018 close): 210.57%

Last price: $24.10

Year-to-date price gain: $16.34

Year-to-date high: $24.89

Year-to-date low: $7.73

Nuvectra develops medical devices that use neurostimulation to . The company recently announced a follow-on public offering of 2,825,000 shares priced at $21.25 per share.

Year-to-date change (as of Oct. 1, 2018 close): 213.84%

Last price: $143.52

Year-to-date price gain: $97.79

Year-to-date high: $161.50

Year-to-date low: $40.70

The Trade Desk offers a that allows customers to manage digital ad campaigns. make The Trade Desk one of the strongest companies in the advertising-tech sector right now.  

Year-to-date change (as of Oct. 1, 2018 close): 214.14%

Last price: $30.66

Year-to-date price gain: $20.90

Year-to-date high: $46.42

Year-to-date low: $9.75

BlueLinx distributes building products like . The company in the first quarter of 2018, 2.1% higher than Q1 of its previous fiscal year.   

Year-to-date change (as of Oct. 1, 2018 close): 214.55%

Last price: $13.84

Year-to-date price gain: $9.44

Year-to-date high: $14.87

Year-to-date low: $4.10

SharpSpring produces a primarily used by marketing agencies on behalf of their clients, mostly small and medium-sized businesses. The company received a record $4.3 million in revenue from its flagship product in the second quarter of 2018.

Year-to-date change (as of Oct. 1, 2018 close): 214.67%

Last price: $219.67

Year-to-date price gain: $149.86

Year-to-date high: $260.98

Year-to-date low: $61.96

This company helps its customers through weight loss coaching and diet food products. Though shares have tripled this year, could lead to some volatility.   

Year-to-date change (as of Oct. 1, 2018 close): 215.49%

Last price: $13.44

Year-to-date price gain: $9.18

Year-to-date high: $13.48

Year-to-date low: $4.19

Xerium produces  while refurbishing and replacing the rolls used in the process. The Austrian firm Andritz for $833 million in cash.

Year-to-date change (as of Oct. 1, 2018 close): 222.11%

Last price: $21.42

Year-to-date price gain: $14.77

Year-to-date high: $31.12

Year-to-date low: $6.11

Funko designs and creates licensed pop culture collectibles of popular franchises like and . Partnerships with have helped Funko skyrocket to success.

Year-to-date change (as of Oct. 1, 2018 close): 226.85%

Last price: $3.53

Year-to-date price gain: $2.45

Year-to-date high: $3.94

Year-to-date low: $0.93

As its name implies, EyePoint Pharmaceuticals develops . , the company recently had several drugs greenlit by the FDA.

Year-to-date change (as of Oct. 1, 2018 close): 226.92%

Last price: $4.25

Year-to-date price gain: $2.95

Year-to-date high: $7.35

Year-to-date low: $1.25

This pharmaceutical company that focuses on cancer immunotherapies made financial news recently . The $96 million agreement led Affimed's shares to double.  

Year-to-date change (as of Oct. 1, 2018 close): 231.06%

Last price: $5.33

Year-to-date price gain: $3.72

Year-to-date high: $10.54

Year-to-date low: $1.46

An energy company, Legacy Reserves . A recently made it more attractive to potential investors.  

Year-to-date change (as of Oct. 1, 2018 close): 231.52%

Last price: $5.47

Year-to-date price gain: $3.82

Year-to-date high: $7.21

Year-to-date low: $1.46

ArQule researches and develops . In late 2017, the company .

Year-to-date change (as of Oct. 1, 2018 close): 254.87%

Last price: $83.75

Year-to-date price gain: $60.15

Year-to-date high: $88.88

Year-to-date low: $23.25

This cloud-based communications company offers a number of cool features, including allowing developers to into any app. The company’s stock fell after a , but it’s still a strong performer in 2018.

Year-to-date change (as of Oct. 1, 2018 close): 271.13%

Last price: $14.40

Year-to-date price gain: $10.52

Year-to-date high: $17.90

Year-to-date low: $3.05

Champions Oncology sells technology that can be used to .  

Year-to-date change (as of Oct. 1, 2018 close): 280.65%

Last price: $27.94

Year-to-date price gain: $20.60

Year-to-date high: $29.60

Year-to-date low: $4.92

This creates pre- and post-transplant diagnostics for patients worldwide. The company will present its new AlloSeq suite of next-generation laboratory products in a symposium later this year.

Year-to-date change (as of Oct. 1, 2018 close): 296.3%

Last price: $55.68

Year-to-date price gain: $41.63

Year-to-date high: $66.14

Year-to-date low: $14

This cloud-based technology company has a unique focus: . After implementing ShotSpotter technologies in Englewood, a notoriously violent neighborhood, Chicago police saw a 43% drop in shootings in 2017.  

Year-to-date change (as of Oct. 1, 2018 close): 298.85%

Last price: $2.78

Year-to-date price gain: $2.08

Year-to-date high: $3.38

Year-to-date low: $0.70

This independent energy company produces crude oil and natural gas in Gabon, Equatorial Guinea, and the United States. VAALCO recently paid off the debt on its balance sheet for the first time since 2014 and increased working capital from continuing operations by $10.9 million.

Year-to-date change (as of Oct. 1, 2018 close): 299.26%

Last price: $16.21

Year-to-date price gain: $12.15

Year-to-date high: $24

Year-to-date low: $3.69

focuses on products that treat metabolic and endocrine disorders. Promising data from a mid-stage trial of a recently caused Viking’s shares to double in value.

Year-to-date change (as of Oct. 1, 2018 close): 299.75%

Last price: $16.03

Year-to-date price gain: $12.02

Year-to-date high: $18.48

Year-to-date low: $2.35

Amarin’s pharmaceutical products primarily target . The company has seen recent success with Vascepa, a purified fish oil that appears to reduce the risk of heart disease or stroke by 25% in at-risk groups.

Year-to-date change (as of Oct. 1, 2018 close): 312.44%

Last price: $8.95

Year-to-date price gain: $6.78

Year-to-date high: $9.99

Year-to-date low: $1.30

New Age Beverages produces . The latest buzz centers around , which will debut at the North American Convenience Store Show in Las Vegas.  

Year-to-date change (as of Oct. 1, 2018 close): 314.74%

Last price: $3.94

Year-to-date price gain: $2.99

Year-to-date high: $6.89

Year-to-date low: $0.82

, this company designs and creates denim apparel for men and women. Differential also , a Hong Kong company that does a lot of licensing in the North American market.

Year-to-date change (as of Oct. 1, 2018 close): 315.19%

Last price: $17.77

Year-to-date price gain: $13.49

Year-to-date high: $20.85

Year-to-date low: $2.81

This biopharmaceutical company takes aim at with its treatments. Endocyte’s stocks recently soared after it announced a .

Year-to-date change (as of Oct. 1, 2018 close): 336.81%

Last price: $12.34

Year-to-date price gain: $9.52

Year-to-date high: $15.92

Year-to-date low: $2.70

This clinical-stage biopharmaceutical company develops treatments for diseases caused by . Despite a big drop in price caused by a recent nerve pain drug , Xenon has still posted strong gains this year.

Year-to-date change (as of Oct. 1, 2018 close): 353.61%

Last price: $4.40

Year-to-date price gain: $3.43

Year-to-date high: $7.19

Year-to-date low: $0.86

This company produces for China's power, petrochemical, coal, metallurgy, construction, and municipal infrastructure development industries. Though it has posted great gains in 2018, it wasn’t without hiccups: NF energy reported a sharp decrease in Q2 revenue year over year.  

Year-to-date change (as of Oct. 1, 2018 close): 354.55%

Last price: $4.00

Year-to-date price gain: $3.12

Year-to-date high: $5.70

Year-to-date low: $0.85

Interestingly, this Swedish pharmaceutical company focuses on both . Oasmia recently reached the end of a trial for Doxophos Vet, a treatment for dogs with lymphoma, and found that 75% of animals showed a response in two treatment cycles.

Year-to-date change (as of Oct. 1, 2018 close): 422.01%

Last price: $19.21

Year-to-date price gain: $15.53

Year-to-date high: $22.39

Year-to-date low: $3.57

Arrowhead Pharmaceutical develops treatments for diseases such as . It’s hepatitis B treatment made news recently when Arrowhead entered into to bring the drug to market.

Year-to-date change (as of Oct. 1, 2018 close): 428.28%

Last price: $3.83

Year-to-date price gain: $3.11

Year-to-date high: $5.33

Year-to-date low: $0.70

This company deals with many aspects of prepaid cards, from . helped the company look attractive on the stock market.

Year-to-date change (as of Oct. 1, 2018 close): 453.81%

Last price: $34.89

Year-to-date price gain: $28.59

Year-to-date high: $52

Year-to-date low: $5.01

AGM is a company that provides trading solutions and other financial technologies for brokerage firms. It recently acquired a minority interest in Matrix International Group, a Canadian startup currency exchange platform.  

Year-to-date change (as of Oct. 1, 2018 close): 526.98%

Last price: $20.22

Year-to-date price gain: $16.99

Year-to-date high: $22.85

Year-to-date low: $2.80

This Dutch biopharmaceutical company develops treatments for . ProQR’s stock surged 70% in September when the company announced that its could actually improve vision.  

Year-to-date change (as of Oct. 1, 2018 close): 636.85%

Last price: $164.98

Year-to-date price gain: $142.59

Year-to-date high: $300

Year-to-date low: $20.10

Tilray represents a new kind of company to trade on the NASDAQ and NYSE: marijuana producers. The Canadian cannabis company became the ; since then, its stock has seen such huge gains that the company is worth more than American Airlines.  

Year-to-date change (as of Oct. 1, 2018 close): 662.61%

Last price: $17.54

Year-to-date price gain: $15.24

Year-to-date high: $18.39

Year-to-date low: $2.30

OptimizeRX provides virtual patient support centers and other technologies that . In the second quarter of 2018, the company’s revenue climbed to a record high of $5.1 million.

Year-to-date change (as of Oct. 1, 2018 close): 815.04%

Last price: $31.02

Year-to-date price gain: $27.63

Year-to-date high: $31.28

Year-to-date low: $2.44

This Luxembourg-based counts some of the world’s top media companies among its customers. It recently to make 5G service possible in the U.S.

Year-to-date change (as of Oct. 1, 2018 close): 985%

Last price: $19.53

Year-to-date price gain: $17.73

Year-to-date high: $34.50

Year-to-date low: $1.64

Audio technology company Turtle Beach provides . Partnerships with other and have helped their stock reach new heights this year.

Year-to-date change (as of Oct. 1, 2018 close): 1,223.11%

Last price: $5.61

Year-to-date price gain: $5.19

Year-to-date high: $7.29

Year-to-date low: $0.38

NII Holdings is a company in the mobile telecommunications sector that put its —a move that could consolidate telecom in the region.

Year-to-date change (as of Oct. 1, 2018 close): 1,534.32%

Last price: $38.57

Year-to-date price gain: $36.21

Year-to-date high: $52.55

Year-to-date low: $2.14

This medical device company concentrates specifically on like insulin pumps. Tandem recently reached agreements to distribute its products in , and , substantially expanding its global footprint.